News Search Results

Displaying Results 2726-2750 of 9182 "San Francisco"

Jan 08, 2026, 09:30 ET AI Investment Accounted for Nearly Half of Healthcare Investment in 2025; Silicon Valley Bank Releases 17th Healthcare Investments and Exits Report

investment in healthcare exceeded $18B in 2025; Investments grew in healthtech and device sectors SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- Artificial Intelligence (AI) dominated the healthcare investment landscape

More news about: Silicon Valley Bank


Jan 08, 2026, 09:00 ET Zenni and Chase Stokes Team Up to Deliver Vision Care to Students in the Charleston Community

function, and style in mind. Based in the San Francisco Bay Area, the company has upended the traditional retail model to become the leader in U.S. online eyewear, with over 70 million frames sold worldwide. Zenni is proud to be the Official Eyewear of the San Francisco 49ers, Boston Celtics, Monster Jam,

More news about: Zenni Optical


Jan 08, 2026, 09:00 ET AXA XL promotes Matthew Stitham to Chief Underwriting Officer, Casualty in the Americas

Jan. 8, 2026 /PRNewswire/ -- AXA XL has promoted Matthew Stitham to Chief Underwriting Officer, Casualty in the Americas.  Based in San Francisco, Mr. Stitham reports to Donna Nadeau, AXA XL's Head of Large Commercial business.  Commenting on the appointment, Ms. Nadeau said, "Matt's

More news about: AXA XL


Jan 08, 2026, 09:00 ET IEQ Capital Names Colin Mark-Griffin, Jeff Sawin, and Jeremy Wenner as Partners

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- IEQ Capital, an independent wealth management firm and multi-family office overseeing $45.9 billion in regulatory assets under management (RAUM)1, announced today the promotion

More news about: IEQ Capital


Jan 08, 2026, 09:00 ET Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity

the full unblinded dataset in Q2–Q3 2026."Tim Boelke (CEO & CMO) and Jonas Dyhrfjeld-Johnsen (CSO & CDO) will attend JPM Week in San Francisco (January 12–15, 2026) and welcome the opportunity to engage with investors and strategic partners during the Biotech Showcase (company presentation:

More news about: Acousia Therapeutics GmbH


Jan 08, 2026, 09:00 ET Verana Health Merges with COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties

to multiply capabilities and services as a leading provider of real-world data for clinical researchSAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- 

More news about: Verana Health


Jan 08, 2026, 09:00 ET Museum of Illusions Announces Majority Investment from Brightwood Capital Advisors to Accelerate Global Expansion

infrastructure, innovation, and long-term value creation."New locations planned for 2026 include Sacramento, London, Birmingham, Miami and San Francisco. Additionally, as part of the transaction, five previously franchised locations, Boston, Chicago, Pittsburgh, Philadelphia, and Scottsdale, will

More news about: Museum of Illusions


Jan 08, 2026, 09:00 ET CraftStory Launches Image-to-Video AI for Long-Form, Studio-Quality Human Videos

Model 2.0 now generates lifelike videos from a single image and a scriptSAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ --

More news about: CraftStory


Jan 08, 2026, 09:00 ET StrongestLayer Research Finds Trusted Platforms Like DocuSign and Google Calendar Are Now the Primary Email Attack Surface

detection with personalized human risk training to protect organizations against both traditional and AI-powered email attacks. Headquartered in San Francisco, StrongestLayer is backed by Sorenson Capital, Recall Capital, and leading cybersecurity industry veterans. Learn more at

More news about: StrongestLayer


Jan 08, 2026, 09:00 ET Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End

8, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief Executive Officer, John Friend, MD, will be in San Francisco next week to participate in meetings during the annual J.P. Morgan Healthcare Conference week (JPM Week). During the week, Kazia will connect

More news about: Kazia Therapeutics Limited


Jan 08, 2026, 09:00 ET Communication Failures Put Nurse Retention, Patient Care at Risk, New Survey Finds

of hospital nurses have learned about new policies or procedures only after they went into effect SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- As hospitals nationwide face persistent staffing shortages and clinical burnout,

More news about: Firstup


Jan 08, 2026, 08:38 ET Mercury Bio Launches MB-TIP™--Revolutionizing Immunotherapy with Intracellular Targeting

approval. The company recently launched its Series A financing round, and will present next week on MB-TIP™ at the annual Biotech Showcase™ in San Francisco. About Mercury Bio: Mercury Bio is an immunology‑driven biotechnology company developing intracellular therapies for neurodegenerative

More news about: Mercury Bio Inc.


Jan 08, 2026, 08:25 ET Immorta Bio Doubles Mouse Lifespan Using Combination Senolytic and Regenerative Therapy in Validated Aging Models

will be presented by Dr. Boris Reznik, Chairman and Chief Executive Officer of Immorta Bio, on January 12 at 2 p.m. PT at Biotech Showcase 2026 in San Francisco, held during J.P. Morgan Healthcare Conference Week.In two validated aging models—carbon tetrachloride (CCl₄)–induced liver injury and doxorubicin-induced

More news about: Immorta Bio Inc.


Jan 08, 2026, 08:00 ET Klotho Neurosciences to Present at the Biotech Showcase 2026

announces that CEO Dr. Joseph Sinkule will be presenting at the 2026 Biotech Showcase in San Francisco on January 13, 2026 at 11:30AM PT.  The Biotech Showcase is to be held January 12-14, 2026 at the Hilton San Francisco Union Square.

More news about: Klotho Neurosciences, Inc.


Jan 08, 2026, 08:00 ET Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere

trained on over $1 billion in Lilly research data accessibledirectly in scientists' workflowsSAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- 

More news about: Benchling


Jan 08, 2026, 08:00 ET OSF Digital Named a Major Player in IDC MarketScape: Worldwide Salesforce Implementation Services 2025-2026 Vendor Assessment

SAN FRANCISCO, Calif., Jan. 8, 2026 /PRNewswire/ - 

More news about: OSF Digital


Jan 08, 2026, 07:30 ET Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

(RCC), today announced strategic updates ahead of its participation in the 15th Annual LifeSci Partners Corporate Access Event taking place in San Francisco, CA, from January 12-14, 2026. This event will be held during the week of the annual J.P. Morgan Healthcare Conference.

More news about: Trevi Therapeutics, Inc.


Jan 08, 2026, 07:15 ET Mill Creek Announces Groundbreaking of Amavi Northwest Austin

offices across the United States. Mill Creek is building its portfolio in many of the nation's most desirable markets in Seattle, Portland, the San Francisco Bay area, Sacramento, Southern California, Salt Lake City, Phoenix, Denver, Dallas, Austin, Houston, South Florida, Tampa, Orlando, Atlanta, Nashville,

More news about: Mill Creek Residential


Jan 08, 2026, 07:15 ET ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

(ADCs), today announced that Ameet Mallik, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Thursday, January 15, 2026, at 10:30 a.m. PT.

More news about: ADC Therapeutics SA


Jan 08, 2026, 06:30 ET Heron Finance expands alternative investments platform, launching new private infrastructure investing strategy

globally diversified private infrastructure investing portfolio with exposure to 1,000+ infrastructure assets.SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- Heron Finance announced today the official launch of its

More news about: Heron Finance


Jan 08, 2026, 03:30 ET Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines

major investor backing. Tom holds an MBA from Stanford University and a BA in Engineering from the University of Cambridge.Tom will be in San Francisco around the J.P. Morgan Healthcare Conference from January 12–15, 2026, where he is available to discuss how the company is advancing its Nanosyringe

More news about: NanoSyrinx


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.